This review comprises the pharmacokinetics and pharmacodynamics of natural and
synthetic estrogens and progestogens used in contraception and therapy, with special …

Aim: To quantify the effects of hormone‐replacement therapy (HRT) on components of the
metabolic syndrome in postmenopausal women. Methods: Comprehensive searches of …

Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …

Objective To assess the association between risk of venous thromboembolism and use of
different types of hormone replacement therapy. Design Two nested case-control studies …

Background—Oral estrogen therapy increases the risk of venous thromboembolism (VTE) in
postmenopausal women. Transdermal estrogen may be safer. However, currently available …

Objective To assess the risk of venous thromboembolism in women using hormone
replacement therapy by study design, characteristics of the therapy and venous …

Background Oral oestrogen-replacement therapy (ERT) activates blood coagulation and
increases the risk of venous thromboembolism (VTE) in postmenopausal women …

Objective—Oral estrogen therapy increases venous thromboembolism risk among
postmenopausal women. Although recent data showed transdermal estrogens may be safe …

OBJECTIVES: The purpose of this review is to focus on the importance of metabolic
syndrome (MBS) and its increased prevalence in postmenopausal (PM) women. Also the …

BACKGROUND The effect of postmenopausal hormone therapy (HT) on cardiovascular
disease (CVD) risk remains controversial. OBJECTIVE AND RATIONALE We aimed to …